NEVVI Medicare utilization intelligence

← back

SHUM, HELEN NPI 1821227273 Clinician

Hematology-Oncology · NEW HYDE PARK, NY

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 17 years since medical school (class of 2009, self-reported to CMS)
Location NEW HYDE PARK, NY · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 63 codes billed · 38,929 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2015-08

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
88185 Flow cytometry technique for dna or cell analysis, each additional marker
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J1100 Injection, dexamethasone sodium phosphate, 1 mg
80053 Blood test, comprehensive group of blood chemicals
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
83615 Lactate dehydrogenase (enzyme) level
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
82784 Gammaglobulin (immune system protein) measurement
83540 Iron level
82728 Ferritin (blood protein) level
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
82607 Cyanocobalamin (vitamin b-12) level
82746 Folic acid level, serum
83521 Measurement of immunoglobulin light chains
82378 Carcinoembryonic antigen (cea) protein level
83550 Iron binding capacity
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
83735 Magnesium level
84550 Uric acid level, blood
84100 Phosphate level
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
96372 Injection of drug or substance under skin or into muscle
84165 Protein measurement, serum
86334 Immunologic analysis technique on serum (immunofixation)
96413 Administration of chemotherapy into vein, 1 hour or less
85044 Red blood count, manual test
88184 Flow cytometry technique for dna or cell analysis, first marker
96375 Injection of additional new drug or substance into vein
96417 Administration of additional new drug or substance into vein, 1 hour or less
83010 Haptoglobin (serum protein) level
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
84443 Blood test, thyroid stimulating hormone (tsh)
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
82232 Beta-2 microglobulin (protein) level
96415 Administration of chemotherapy into vein, each additional hour
96374 Injection of drug or substance into vein
J1200 Injection, diphenhydramine hcl, up to 50 mg
86301 Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated
82668 Erythropoietin (protein) level
96361 Infusion into a vein for hydration, each additional hour
80074 Acute hepatitis panel
85610 Blood test, clotting time
99195 Drawing of blood for a medical problem
84153 Psa (prostate specific antigen) measurement, total
85730 Coagulation assessment blood test, plasma or whole blood
81002 Urinalysis, manual test
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
96360 Infusion into a vein for hydration, 31-60 minutes
J7050 Infusion, normal saline solution, 250 cc
84439 Thyroxine (thyroid chemical), free
81219 Gene analysis (calreticulin), common variants
81270 Gene analysis (janus kinase 2) variant
81279 Gene analysis (janus kinase 2) targeted sequence analysis
81338 Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants
86431 Rheumatoid factor level
G0452 Molecular pathology procedure; physician interpretation and report

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.